Overview

GT Bio builds Deliveromics, a platform that creates an in vivo drug delivery atlas by combining spatial biology, machine learning, and targeted conjugates to enable scalable, cell-type-specific delivery in living organisms. It uses high-throughput in vivo screening to collect data and predict the design of delivery vehicles like ligand-conjugated lipid nanoparticles, aiming to shorten timelines and reduce costs vs traditional methods. The platform differentiates itself by tightly integrating spatial context with AI to model delivery across brain, immune system, and other tissues, offering a data-driven path to precision therapies and enabling collaborators in academia and industry to accelerate their research and development. GT Bio’s goal is to enable scalable, cell-type-specific precision therapies by providing delivery solutions and an adaptable platform for researchers and companies.